Distinguished Professor Blake Peterson earned a B.S. in Chemistry from the University of Nevada, Reno and a Ph.D. in chemistry from the University of California, Los Angeles. He was a Damon Runyon-Walter Winchell Cancer Research Foundation Postdoctoral Fellow at Harvard University from 1995-1998, an American Cancer Society Research Scholar in 2003, and a Camille Dreyfus Teacher Scholar in 2003.
The Peterson laboratory in the Department of Medicinal Chemistry at The University of Kansas pursues interdisciplinary research in the fields of bioorganic / medicinal chemistry and chemical biology. We create and study anticancer agents, antiviral agents, molecular probes, tools for target identification, and systems for drug delivery. Expertise includes synthesis of steroids, lipids, nucleosides, peptides, heterocycles, fluorophores, and protein conjugates, and evaluation of these agents in biochemical assays, whole cells, and animal models.
- Organic synthesis
- Chemical biology
- Anticancer agents
- Drug delivery systems
The Peterson lab focuses on the design, synthesis, and evaluation of biologically active small molecules. Their core science is organic chemistry, and they use modern methods of solution-phase and solid-phase synthesis to prepare modulators of biological pathways and probes of cellular biology. To investigate the activity and potency of these compounds, they employ diverse cellular and biochemical assays, with a particular emphasis on fluorescence-based techniques.